Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A21010 HRP, Goat Anti-Mouse IgG Genetic Association and Drug Target Exploration Between Inflammation-Related Proteins and the Risk of Primary Ovarian Insufficiency(A21010-4.1) 4.1 Veterinary Microbiology
A21010 HRP, Goat Anti-Mouse IgG Genetic effects of the EIF5A2 gene on chicken growth and skeletal muscle development(A21010-2) 2 Livestock Science
BMS0050 Normal Goat Serum Genetic deletion of zinc transporter ZnT3 induces progressive cognitive deficits in mice by impairing dendritic spine plasticity and glucose metabolism.(BMS0050-4) 4 Frontiers in Molecular Neuroscience
A23210 DyLight 488, Goat Anti-Mouse IgG Genetic variation in ZmWAX2 confers maize resistance to Fusarium verticillioides(A23210-14) 14 Plant Biotechnol J
BMU108 Genetic Regulation of Alternative Polyadenylation ProvidesNovel Insights into Molecular Mechanisms UnderlyingNon-small Cell Lung Cancer(BMU108-14.1) 14.1 Nature Communications
KTA1020 Cell Counting Kit-8 (CCK-8) Genetically engineered MSC vesicles encapsulated with dual-gene siRNAs integrated peptide dendrimer nanoplatform for rheumatoid arthritis treatment(KTA1020-13.2) 13.2 Journal of Experimental & Clinical Cancer Research
KTA0002 Annexin V-AbFluor™ 488/PI Apoptosis Detection kit Genetically engineered MSCs overexpressing hepatocyte growth factor for the treatment of human refractory wounds.(KTA0002-21.1) 21.1  Nano Today 
Abp51894 Na+/K+-ATPase α1 Polyclonal Antibody Genetically engineered nano‐melittin vesicles for multimodal synergetic cancer therapy(Abp51894-7) 7 Bioengineering & Translational Medicine
KTB1420 CheKine™ Micro Aspartate Aminotransferase (AST/GOT) Activity Assay Kit Genetically engineered nanovesicles based anti-EphA2/CD3 bispecific antibody promotes T cell immune response for triple negative breast cancer treatment(KTB1420-13.2) 13.2 researchsquare
KTB1410 CheKine™ Micro Alanine Aminotransferase (ALT/GPT) Activity Assay Kit Genetically engineered nanovesicles based anti-EphA2/CD3 bispecific antibody promotes T cell immune response for triple negative breast cancer treatment(KTB1410-13.2) 13.2 Research Square